13D Filing: Mill Road Capital II, L.P. and Performant Financial Corp (PFMT)

Page 1 of 10

Performant Financial Corp (NASDAQ:PFMT): Thomas E. Lynch’s Mill Road Capital II, L.P. filed an amended 13D.

You can check out Mill Road Capital II, L.P.’s latest holdings and filings here.

Please follow Mill Road Capital II, L.P. (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Mill Road Capital II, L.P. or update its stock holdings.

Follow Thomas Lynch's Mill Road Capital Management

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Mill Road Capital II 3,440,023 9. 3,440,023 11. 3,440,023 6.8%
Mill Road Capital II GP 3,440,023 9. 3,440,023 11. 3,440,023 6.8%
Thomas E. Lynch 8. 3,440,023 10. 3,440,023 3,440,023 6.8%
Scott P. Scharfman 8. 3,440,023 10. 3,440,023 3,440,023 6.8%

Page 1 of 10 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No.    )*

Performant
Financial Corporation

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

71377E105

(CUSIP Number)

Mill Road Capital II, L.P.

Attn: Thomas E. Lynch

382 Greenwich Avenue

Suite One

Greenwich, CT
06830

203-987-3500

With a copy to:

Peter M. Rosenblum, Esq.

Foley Hoag LLP

155
Seaport Blvd.

Boston, MA 02210

617-832-1151

(Name,
Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

January 18, 2018

(Date of Event which Requires Filing of this Statement)

If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box.  ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for
other parties to whom copies are sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).

Follow Performant Healthcare Inc (NASDAQ:PFMT)

Page 1 of 10